Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC
Clinical trial NCT05192798 · RECRUITING
Trial details
- NCT number
- NCT05192798
- Sponsor
- The First Affiliated Hospital of Bengbu Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2025-09-10
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.